FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to ophthalmology, and can be used for treating inflammatory or dystrophic eye diseases. For this purpose, in 2–4 weeks after the anti-inflammatory or anti-dystrophy therapy, the autologous thrombocyte lysate is injected 0.6–0.8 ml sub-conjunctivally or 0.8–1.0 ml paravequatorially, with course of 4–6 injections, with interval of 48–72 hours.
EFFECT: method provides accelerating natural mechanisms of tissue regeneration, reducing a recurrence rate of the disease, preventing complications, improving visual functions due to the anti-inflammatory, anti-edema and reparative action of the therapy.
3 cl, 10 dwg, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR COMPLEX TREATMENT OF ENDOGENOUS UVEITIS FOLLOWED BY MACULAR EDEMA | 2016 |
|
RU2635083C1 |
| METHOD FOR CENTRAL SEROUS CHORIORETINOPATHY THERAPY | 2016 |
|
RU2629804C1 |
| METHOD OF TREATING UVEITIS IN CHILDREN | 2023 |
|
RU2817969C1 |
| METHOD FOR COMBINED SURGICAL TREATMENT OF GLAUCOMA IN COMBINATION WITH CATARACT | 2021 |
|
RU2769820C1 |
| METHOD OF COMBINED CONSERVATIVE TREATMENT OF ACTIVE ENDOCRINE OPHTHALMOPATHY | 2022 |
|
RU2806503C1 |
| METHOD FOR INTRAOPERATIVE FIXATION OF A SUBLUXATED LENS IN PHACOEMULSIFICATION OR LASER EXTRACTION WITH INTRAOCULAR LENS IMPLANTATION | 2019 |
|
RU2699535C1 |
| METHOD FOR TREATING UVEITIS IN CHILDREN | 1999 |
|
RU2185193C2 |
| METHOD FOR TREATING OEDEMATOUS FORM OF DIABETIC MACULORETINOPAHTY | 2008 |
|
RU2367386C1 |
| METHOD OF SURGICAL TREATMENT OF END-TO-END IDIOPATHIC MACULAR RUPTURES OF THE RETINA | 2017 |
|
RU2652076C1 |
| METHOD FOR INTRAOPERATIVE EXAMINATION OF CENTRAL AND PERIPHERAL EYE GROUND FOLLOWING PHACOEMULSIFICATION OR LASER EXTRACTION OF CATARACT | 2013 |
|
RU2553194C1 |
